N/A N=7,879 Triple-blind Treatment

Education Bundle to Decrease Patient Refusal of VTE Prophylaxis

Venous Thromboembolism · Deep Venous Thrombosis · Pulmonary Embolism

Bottom Line

View on ClinicalTrials.gov: NCT02402881 ↗

Enrolled (actual)

7,879

Serious AEs

0.0%

Results posted

Jan 2020

Primary outcome: Primary: Percentage of Non Administration of Prescribed VTE Prophylaxis Medication Doses — 9.1; 13.6; 5.6; 13.3 Percentage of nonadministration — p=<0.05

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Patient-centered education bundle (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Johns Hopkins University
Primary completion: Nov 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Non Administration of Prescribed VTE Prophylaxis Medication Doses	9.1; 13.6; 5.6; 13.3	<0.05 sig
SECONDARY Number of Participants With Venous Thromboembolism	7; 14; 6; 17	<0.05 sig

Summary

The investigators have recently developed a registry of missed doses of VTE prophylaxis that includes retrospective data on missed doses of VTE prophylaxis. To decrease rates of VTE prophylaxis refusal, the group has developed a patient-centered education bundle that will be delivered as an in-person, 1-on-1 discussion session with a nurse educator. Supporting education materials include a 2-page education sheet and an educational video. The investigators hypothesize that patient refusal of VTE prophylaxis is associated with significant knowledge gaps among patients regarding patients' risk of developing VTE and the benefits of VTE prophylaxis and that delivering an education bundle to patients that refuse VTE prophylaxis will improve compliance with VTE prophylaxis and decrease rates of VTE.

Eligibility Criteria

Inclusion Criteria

All patients on the four trial floors who miss at least one dose of VTE prophylaxis will be included in the study.

Exclusion Criteria

N/A

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02402881). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.